Illumina, Inc. (ILMN) stock analysis

In our weekly check, Illumina, Inc. is graded B (A to F). Of 23 checks on debt, profit, cash flow and trend: 16 pass, warnings: 4, red flags: 3.

About Illumina, Inc.

Illumina, Inc. is a Healthcare company (Diagnostics & Research) based in the United States, listed on NASDAQ as ILMN.

What our checks show for ILMN

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-04

Similar companies

LH · DGX · MTD · IQV · WAT · NTRA

Questions

What grade does Illumina, Inc. (ILMN) have?

In our weekly check, Illumina, Inc. is graded B (A to F). Of 23 checks on debt, profit, cash flow and trend: 16 pass, warnings: 4, red flags: 3. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of ILMN stock?

This week's biggest flags for Illumina, Inc.: Weak revenue growth, Very volatile, Deep past fall. In total 7 of 23 checks show a warning or a red flag.

What does Illumina, Inc. do?

Illumina, Inc. is a Healthcare company (Diagnostics & Research) based in the United States, listed on NASDAQ as ILMN.

When does Illumina, Inc. report earnings next?

The next earnings report is expected on 2027-02-04. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis